Rectal Neoplasms: all 1,804 studies

Page 7 of 19. Open to participants first (520), then studies with results posted, then the rest; newest registration first within each.

• Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal CancerCompletedNCT01652196Phase 2Results posted
• Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver MetastasesCompletedNCT01643070Phase 2Results posted
• A Trial of Dalotuzumab in Combination With Irinotecan Versus Cetuximab and Irinotecan for Participants With Metastatic Rectal Cancers (mRC) (MK-0646-025)TerminatedNCT01609231Phase 2Results posted
• Safety Study of Capecitabine With Radiation in Elderly Rectal CancerCompletedNCT01584544Phase 1Results posted
• Perfusion Assessment in Laparoscopic Left Anterior ResectionCompletedNCT01560377Phase 1Results posted
• Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO TrialActive, not recruitingNCT01558921Phase 3Results posted
• Compare Preperitoneal Analgesia to Epidural Analgesia for Pain Control After Colon and Rectal SurgeryCompletedNCT01552226Not applicableResults posted
• PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing SurgeryActive, not recruitingNCT01515787Phase 2/3Results posted
• Tecemotide (L-BLP25) in Rectal CancerCompletedNCT01507103Phase 2Results posted
• Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal CancerCompletedNCT01481545Phase 2Results posted
• Fluorescent Evaluation of Colorectal AnastamosesCompletedNCT01424293Not applicableResults posted
• Dose Escalation Trial of Nitroglycerin, 5-flourouracil and Rad Therapy for Rectal CancerCompletedNCT01407107Phase 1Results posted
• Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal CarcinomaCompletedNCT01394939Phase 1/2Results posted
• Phase 1b Dose Escalation Study of Intravenous JX-594 in Metastatic, Refractory Colorectal CarcinomaCompletedNCT01380600Phase 1Results posted
• Linifanib in Treating Patients With Advanced, Refractory Colorectal CancerTerminatedNCT01365910Phase 2Results posted
• Complete Neoadjuvant Treatment for REctal Cancer (CONTRE)CompletedNCT01363843Phase 2Results posted
• Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal CancerTerminatedNCT01347645Phase 1/2Results posted
• Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal CancerCompletedNCT01345175Phase 3Results posted
• An Observational Study of Xeloda (Capecitabine) and Oxaliplatin Prior and Concurrent To Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal CancerCompletedNCT01339832Results posted
• Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal CancerTerminatedNCT01320683Phase 2Results posted
• Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal CancerTerminatedNCT01285102Phase 1Results posted
• Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer PatientsCompletedNCT01268943Phase 1Results posted
• A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer.CompletedNCT01227707Phase 2Results posted
• Study of High-Dose-Rate Endorectal Brachytherapy (HDRBT) in the Treatment of Locally Advanced Low Rectal CancerCompletedNCT01226979Not applicableResults posted
• Sexual Function and Wellbeing in Males With Rectal CancerCompletedNCT01216202Results posted
• Sexual Function and Wellbeing in Females With Rectal CancerCompletedNCT01216189Results posted
• Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal CancerTerminatedNCT01148056Not applicableResults posted
• A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the RectumTerminatedNCT01134601Phase 1Results posted
• RO4929097 in Treating Patients With Metastatic Colorectal CancerCompletedNCT01116687Phase 2Results posted
• Clinical and Translational Study of STA-9090CompletedNCT01111838Phase 2Results posted
• Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal CancerCompletedNCT01105377Phase 2Results posted
• Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in TumorsCompletedNCT01075399Phase 2Results posted
• Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal CancerCompletedNCT01060007Phase 2Results posted
• NITI CAR27 (ColonRing) Compression Anastomosis in Colorectal SurgeryCompletedNCT01056913Phase 4Results posted
• Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With CancerCompletedNCT01037790Phase 2Results posted
• Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous TreatmentCompletedNCT00942266Phase 2Results posted
• The Stockholm III Trial on Different Preoperative Radiotherapy Regimens in Rectal CancerCompletedNCT00904813Not applicableResults posted
• A Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal CancerCompletedNCT00865189Phase 2Results posted
• Exploratory Study Of The ERCC-1 GeneCompletedNCT00846482Not applicableResults posted
• A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Participants With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and BevacizumabTerminatedNCT00845039Phase 2Results posted
• Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by SurgeryTerminatedNCT00835679Early Phase 1Results posted
• Neo-Adjuvant FOLFOX for Rectal CarcinomaTerminatedNCT00832299Phase 2Results posted
• Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal CancerCompletedNCT00831181Phase 2Results posted
• Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal CancerCompletedNCT00828672Phase 2Results posted
• Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal CancerCompletedNCT00826540Phase 2Results posted
• PEAK: Panitumumab Plus mFOLFOX6 vs. Bevacizumab Plus mFOLFOX6 for First Line Treatment of Metastatic Colorectal Cancer (mCRC) Patients With Wild-Type Kirsten Rat Sarcoma-2 Virus (KRAS) TumorsCompletedNCT00819780Phase 2Results posted
• Chemoembolization, Irinotecan Bead, Second Line Chemotherapy Treatment of Unresectable Metastatic Colorectal CancerTerminatedNCT00816777Phase 1/2Results posted
• Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal CancerCompletedNCT00807911Phase 2Results posted
• A Study of Xeloda (Capecitabine) Plus Radiotherapy in Participants With Locally Advanced Rectal CancerCompletedNCT00796718Phase 2Results posted
• Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)CompletedNCT00788957Phase 1/2Results posted
• Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal CancerTerminatedNCT00766142Phase 2Results posted
• Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or AdenomaCompletedNCT00754494Phase 2Results posted
• Radiation Therapy and Capecitabine With or Without Curcumin Before Surgery in Treating Patients With Rectal CancerTerminatedNCT00745134Phase 2Results posted
• Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Rectal CancerCompletedNCT00726622Phase 3Results posted
• The Sexual Health of Rectal Cancer PatientsCompletedNCT00712751Results posted
• S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal CancerCompletedNCT00686166Phase 2Results posted
• Genotype-directed Neoadjuvant Chemoradiation for Rectal CarcinomaCompletedNCT00682786Phase 2Results posted
• Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal AnastomosesTerminatedNCT00663819Not applicableResults posted
• Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With SurgeryCompletedNCT00645710Phase 1/2Results posted
• Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal CancerCompletedNCT00613080Phase 2Results posted
• Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal CancerTerminatedNCT00611858Phase 2Results posted
• Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain MetastasesCompletedNCT00587964Phase 2Results posted
• Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal CancerCompletedNCT00551421Phase 1/2Results posted
• Concentration of Ertapenem in Colorectal TissueCompletedNCT00535652Phase 4Results posted
• Pre-op Rectal ChemoRad +/- CetuximabCompletedNCT00527111Phase 2Results posted
• The Role of Biofeedback in Improving Continence After Anterior ResectionCompletedNCT00515853Not applicableResults posted
• Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal CancerCompletedNCT00504153Phase 2Results posted
• Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line TherapyTerminatedNCT00499369Phase 3Results posted
• Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal CancerCompletedNCT00462501Not applicableResults posted
• VEGF Trap in Treating Patients With Previously Treated Metastatic Colorectal CancerCompletedNCT00407654Phase 2Results posted
• AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal CancerTerminatedNCT00397878Phase 2Results posted
• Irinotecan and Cetuximab for Colorectal Cancer as Second Line TherapyCompletedNCT00336856Phase 2Results posted
• A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer.CompletedNCT00330915Phase 2Results posted
• Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal CancerCompletedNCT00321685Phase 2Results posted
• 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal CancerCompletedNCT00308516Phase 2Results posted
• Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal CancerCompletedNCT00307736Phase 1/2Results posted
• Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal CancerTerminatedNCT00303628Phase 3Results posted
• Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal CancerCompletedNCT00265850Phase 3Results posted
• Cellular Immune Augmentation in Colon and Rectal CancerCompletedNCT00257322Phase 2Results posted
• Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal CancerTerminatedNCT00250835Phase 2Results posted
• A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal CancerTerminatedNCT00226941Phase 1/2Results posted
• Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal CancerTerminatedNCT00216086Phase 2Results posted
• Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal CancerCompletedNCT00114231Phase 2Results posted
• Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal CancerCompletedNCT00113230Phase 2Results posted
• SB-715992 in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00103311Phase 2Results posted
• Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal CancerCompletedNCT00100841Phase 2Results posted
• Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal CancerCompletedNCT00081289Phase 2Results posted
• Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal CancerCompletedNCT00068692Phase 3Results posted
• Purse-String Versus Linear Closure After Ileostomy ReversalCompletedNCT07892404Not applicable
• Robotic vs Laparoscopic and Open Surgery for Abdominopelvic CancersCompletedNCT07821775
• Learning Curve of SILS in CRCCompletedNCT07736131
• Predictors of Rescue Surgery, Mortality, and Permanent Stoma After Anastomotic Leak Following Colorectal Cancer ResectionCompletedNCT07725692
• Autologous Fecal Microbiota Transplantation for Anal Function Recovery After Ileostomy Reversal in Rectal CancerActive, not recruitingNCT07711509Not applicable
• Self Regulation Hypnotic Intervention for Pain and Anxiety During Rectal BrachytherapyCompletedNCT07619768Not applicable
• Optimization and Standardization of Single-Port Robotic Transanal Minimally Invasive Surgery for Rectal Tumor ExcisionActive, not recruitingNCT07522294Not applicable
• Predicting Pathological Complete Response in Rectal Cancer Using Machine LearningActive, not recruitingNCT07509632
• Concentrated Complex Plant Dietary Elements for Chemotherapy-Induced DiarrheaCompletedNCT07460596Phase 2
• Local Treatment Strategies for Brain Metastases of Colorectal CancerActive, not recruitingNCT07448662
• Pelvic Floor Peritoneal Closure to Prevent Postoperative Ileus in Mid-Low Rectal Cancer SurgeryActive, not recruitingNCT07432542Not applicable
• ColoSeal™ ICD System Anastomotic Protection Pivotal StudyActive, not recruitingNCT07429110Not applicable

← Rectal Neoplasms overview